Literature DB >> 33876727

Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2.

Salwa Naushin1, Viren Sardana2, Rajat Ujjainiya1, Nitin Bhatheja2, Rintu Kutum2, Akash Kumar Bhaskar1, Shalini Pradhan1, Satyartha Prakash2, Raju Khan3, Birendra Singh Rawat4, Karthik Bharadwaj Tallapaka5, Mahesh Anumalla5, Giriraj Ratan Chandak5, Amit Lahiri6, Susanta Kar6, Shrikant Ramesh Mulay6, Madhav Nilakanth Mugale6, Mrigank Srivastava6, Shaziya Khan6, Anjali Srivastava6, Bhawana Tomar6, Murugan Veerapandian7, Ganesh Venkatachalam7, Selvamani Raja Vijayakumar7, Ajay Agarwal8, Dinesh Gupta8, Prakash M Halami9, Muthukumar Serva Peddha9, Gopinath M Sundaram9, Ravindra P Veeranna9, Anirban Pal10, Vinay Kumar Agarwal10, Anil Ku Maurya10, Ranvijay Kumar Singh11, Ashok Kumar Raman11, Suresh Kumar Anandasadagopan12, Parimala Karuppanan12, Subramanian Venkatesan12, Harish Kumar Sardana13, Anamika Kothari13, Rishabh Jain13, Anupama Thakur13, Devendra Singh Parihar13, Anas Saifi13, Jasleen Kaur13, Virendra Kumar13, Avinash Mishra14, Iranna Gogeri15, Geethavani Rayasam16, Praveen Singh17, Rahul Chakraborty18, Gaura Chaturvedi17, Pinreddy Karunakar17, Rohit Yadav17, Sunanda Singhmar17, Dayanidhi Singh17, Sharmistha Sarkar17, Purbasha Bhattacharya17, Sundaram Acharya17, Vandana Singh17, Shweta Verma17, Drishti Soni17, Surabhi Seth17, Sakshi Vashisht17, Sarita Thakran17, Firdaus Fatima17, Akash Pratap Singh17, Akanksha Sharma17, Babita Sharma17, Manikandan Subramanian17, Yogendra S Padwad19, Vipin Hallan20, Vikram Patial20, Damanpreet Singh20, Narendra Vijay Tripude20, Partha Chakrabarti21, Sujay Krishna Maity21, Dipyaman Ganguly21, Jit Sarkar21, Sistla Ramakrishna22, Balthu Narender Kumar22, Kiran A Kumar22, Sumit G Gandhi23, Piyush Singh Jamwal23, Rekha Chouhan23, Vijay Lakshmi Jamwal23, Nitika Kapoor23, Debashish Ghosh24, Ghanshyam Thakkar24, Umakanta Subudhi25, Pradip Sen26, Saumya Ray Chaudhury26, Rashmi Kumar26, Pawan Gupta26, Amit Tuli26, Deepak Sharma27, Rajesh P Ringe26, Amarnarayan D28, Mahesh Kulkarni29, Dhansekaran Shanmugam30, Mahesh S Dharne31, Sayed G Dastager31, Rakesh Joshi31, Amita P Patil31, Sachin N Mahajan31, Abujunaid Habib Khan31, Vasudev Wagh31, Rakesh Kumar Yadav31, Ajinkya Khilari31, Mayuri Bhadange31, Arvindkumar H Chaurasiya31, Shabda E Kulsange31, Krishna Khairnar32, Shilpa Paranjape32, Jatin Kalita33, Narahari G Sastry33, Tridip Phukan33, Prasenjit Manna33, Wahengbam Romi33, Pankaj Bharali33, Dibyajyoti Ozah33, Ravi Kumar Sahu33, Elapavalooru Vssk Babu34, Rajeev Sukumaran35, Aiswarya R Nair35, Prajeesh Kooloth Valappil35, Anoop Puthiyamadam35, Adarsh Velayudhanpillai35, Kalpana Chodankar36, Samir Damare36, Yennapu Madhavi37, Ved Varun Aggarwal38, Sumit Dahiya38, Anurag Agrawal39, Debasis Dash40, Shantanu Sengupta1.   

Abstract

To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India), conducted a sero-survey across its constituent laboratories and centers across India. Of 10,427 volunteers, 1058 (10.14%) tested positive for SARS CoV2 anti-nucleocapsid (anti-NC) antibodies; 95% of which had surrogate neutralization activity. Three-fourth of these recalled no symptoms. Repeat serology tests at 3 (n=607) and 6 (n=175) months showed stable anti-NC antibodies but declining neutralization activity. Local sero-positivity was higher in densely populated cities and was inversely correlated with a 30 day change in regional test positivity rates (TPR). Regional seropositivity above 10% was associated with declining TPR. Personal factors associated with higher odds of sero-positivity were high-exposure work (Odds Ratio, 95% CI, p value; 2∙23, 1∙92-2∙59, <0.0001), use of public transport (1∙79, 1∙43-2∙24, <0.0001), not smoking (1∙52, 1∙16-1∙99, 0∙0257), non-vegetarian diet (1∙67, 1∙41-1∙99, <0.0001), and B blood group (1∙36,1∙15-1∙61, 0∙001).
© 2021, Naushin et al.

Entities:  

Keywords:  medicine; viruses

Year:  2021        PMID: 33876727     DOI: 10.7554/eLife.66537

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  10 in total

1.  Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India.

Authors:  Mahesh S Dhar; Robin Marwal; Radhakrishnan Vs; Kalaiarasan Ponnusamy; Bani Jolly; Rahul C Bhoyar; Viren Sardana; Salwa Naushin; Mercy Rophina; Thomas A Mellan; Swapnil Mishra; Charles Whittaker; Saman Fatihi; Meena Datta; Priyanka Singh; Uma Sharma; Rajat Ujjainiya; Nitin Bhatheja; Mohit Kumar Divakar; Manoj K Singh; Mohamed Imran; Vigneshwar Senthivel; Ranjeet Maurya; Neha Jha; Priyanka Mehta; Vivekanand A; Pooja Sharma; Arvinden Vr; Urmila Chaudhary; Namita Soni; Lipi Thukral; Seth Flaxman; Samir Bhatt; Rajesh Pandey; Debasis Dash; Mohammed Faruq; Hemlata Lall; Hema Gogia; Preeti Madan; Sanket Kulkarni; Himanshu Chauhan; Shantanu Sengupta; Sandhya Kabra; Ravindra K Gupta; Sujeet K Singh; Anurag Agrawal; Partha Rakshit; Vinay Nandicoori; Karthik Bharadwaj Tallapaka; Divya Tej Sowpati; K Thangaraj; Murali Dharan Bashyam; Ashwin Dalal; Sridhar Sivasubbu; Vinod Scaria; Ajay Parida; Sunil K Raghav; Punit Prasad; Apurva Sarin; Satyajit Mayor; Uma Ramakrishnan; Dasaradhi Palakodeti; Aswin Sai Narain Seshasayee; Manoj Bhat; Yogesh Shouche; Ajay Pillai; Tanzin Dikid; Saumitra Das; Arindam Maitra; Sreedhar Chinnaswamy; Nidhan Kumar Biswas; Anita Sudhir Desai; Chitra Pattabiraman; M V Manjunatha; Reeta S Mani; Gautam Arunachal Udupi; Priya Abraham; Potdar Varsha Atul; Sarah S Cherian
Journal:  Science       Date:  2021-10-14       Impact factor: 47.728

2.  Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.

Authors:  Nupur Biswas; Priyanka Mallick; Sujay Krishna Maity; Debaleena Bhowmik; Arpita Ghosh Mitra; Soumen Saha; Aviral Roy; Partha Chakrabarti; Sandip Paul; Saikat Chakrabarti
Journal:  Front Microbiol       Date:  2021-07-29       Impact factor: 5.640

Review 3.  Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.

Authors:  Nuzrath Jahan; Adarsha Brahma; Muthusamy Santhosh Kumar; Bhavani Shankara Bagepally; Manickam Ponnaiah; Tarun Bhatnagar; Manoj V Murhekar
Journal:  Int J Infect Dis       Date:  2021-12-28       Impact factor: 12.074

4.  Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases.

Authors:  Kaushik Sen; Sudeshna Datta; Arup Ghosh; Atimukta Jha; Abdul Ahad; Sanchari Chatterjee; Sandhya Suranjika; Soumya Sengupta; Gargee Bhattacharya; Omprakash Shriwas; Kiran Avula; Jayasingh Kshatri; Punit Prasad; Rajeeb Swain; Ajay K Parida; Sunil K Raghav
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

5.  COVID-19: Impact on linguistic and genetic isolates of India.

Authors:  Prajjval Pratap Singh; Prashanth Suravajhala; Chandana Basu Mallick; Rakesh Tamang; Ashutosh Kumar Rai; Pratheusa Machha; Royana Singh; Abhishek Pathak; Vijay Nath Mishra; Pankaj Shrivastava; Keshav K Singh; Kumarasamy Thangaraj; Gyaneshwer Chaubey
Journal:  Genes Immun       Date:  2021-10-11       Impact factor: 2.676

6.  High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge.

Authors:  Rajat Ujjainiya; Akansha Tyagi; Viren Sardana; Salwa Naushin; Nitin Bhatheja; Kartik Kumar; Joydeb Barman; Satyartha Prakash; Rintu Kutum; Akash Kumar Bhaskar; Prateek Singh; Kumardeep Chaudhary; Menka Loomba; Yukti Khanna; Chestha Walecha; Rizwan Ahmed; Ashutosh Yadav; Archana Bajaj; Gaurav Malik; Sahar Qureshi; Swati Waghdhare; Samreen Siddiqui; Kamal Krishan Trehan; Manju Mani; Rajiv Dang; Poonam Das; Pankaj Dougall; Monica Mahajan; Sudipta Sonar; Kamini Jakhar; Reema Kumar; Mahima Tiwari; Shailendra Mani; Sankar Bhattacharyya; Sandeep Budhiraja; Anurag Agrawal; Debasis Dash; Sujeet Jha; Shantanu Sengupta
Journal:  Nat Commun       Date:  2022-04-01       Impact factor: 14.919

7.  Sero-Surveillance to Monitor the Trend of SARS-CoV-2 Infection Transmission in India: Study Protocol for a Multi Site, Community Based Longitudinal Cohort Study.

Authors:  Divya Nair; Reshma Raju; Sudipto Roy; Shailendra Dandge; Girish Kumar Chethrapilly Purushothaman; Yuvaraj Jayaraman; Boopathi Kangusamy; Rahul Shrivastava; Narendra Kumar Arora; Winsley Rose; Sanjay Juvekar; Guru Rajesh Jammy; Kavita Singh; Sanjay Mehendale; Prabu Rajkumar; Shikha Taneja Malik
Journal:  Front Public Health       Date:  2022-03-24

8.  Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.

Authors:  Sanjeet Kumar; Kanika Bansal
Journal:  Virus Res       Date:  2021-11-22       Impact factor: 3.303

9.  A machine learning-based approach to determine infection status in recipients of BBV152 (Covaxin) whole-virion inactivated SARS-CoV-2 vaccine for serological surveys.

Authors:  Prateek Singh; Rajat Ujjainiya; Satyartha Prakash; Salwa Naushin; Viren Sardana; Nitin Bhatheja; Ajay Pratap Singh; Joydeb Barman; Kartik Kumar; Saurabh Gayali; Raju Khan; Birendra Singh Rawat; Karthik Bharadwaj Tallapaka; Mahesh Anumalla; Amit Lahiri; Susanta Kar; Vivek Bhosale; Mrigank Srivastava; Madhav Nilakanth Mugale; C P Pandey; Shaziya Khan; Shivani Katiyar; Desh Raj; Sharmeen Ishteyaque; Sonu Khanka; Ankita Rani; Jyotsna Sharma; Anuradha Seth; Mukul Dutta; Nishant Saurabh; Murugan Veerapandian; Ganesh Venkatachalam; Deepak Bansal; Dinesh Gupta; Prakash M Halami; Muthukumar Serva Peddha; Ravindra P Veeranna; Anirban Pal; Ranvijay Kumar Singh; Suresh Kumar Anandasadagopan; Parimala Karuppanan; Syed Nasar Rahman; Gopika Selvakumar; Subramanian Venkatesan; Malay Kumar Karmakar; Harish Kumar Sardana; Anamika Kothari; Devendra Singh Parihar; Anupma Thakur; Anas Saifi; Naman Gupta; Yogita Singh; Ritu Reddu; Rizul Gautam; Anuj Mishra; Avinash Mishra; Iranna Gogeri; Geethavani Rayasam; Yogendra Padwad; Vikram Patial; Vipin Hallan; Damanpreet Singh; Narendra Tirpude; Partha Chakrabarti; Sujay Krishna Maity; Dipyaman Ganguly; Ramakrishna Sistla; Narender Kumar Balthu; Kiran Kumar A; Siva Ranjith; B Vijay Kumar; Piyush Singh Jamwal; Anshu Wali; Sajad Ahmed; Rekha Chouhan; Sumit G Gandhi; Nancy Sharma; Garima Rai; Faisal Irshad; Vijay Lakshmi Jamwal; Masroor Ahmad Paddar; Sameer Ullah Khan; Fayaz Malik; Debashish Ghosh; Ghanshyam Thakkar; S K Barik; Prabhanshu Tripathi; Yatendra Kumar Satija; Sneha Mohanty; Md Tauseef Khan; Umakanta Subudhi; Pradip Sen; Rashmi Kumar; Anshu Bhardwaj; Pawan Gupta; Deepak Sharma; Amit Tuli; Saumya Ray Chaudhuri; Srinivasan Krishnamurthi; L Prakash; Ch V Rao; B N Singh; Arvindkumar Chaurasiya; Meera Chaurasiyar; Mayuri Bhadange; Bhagyashree Likhitkar; Sharada Mohite; Yogita Patil; Mahesh Kulkarni; Rakesh Joshi; Vaibhav Pandya; Sachin Mahajan; Amita Patil; Rachel Samson; Tejas Vare; Mahesh Dharne; Ashok Giri; Sachin Mahajan; Shilpa Paranjape; G Narahari Sastry; Jatin Kalita; Tridip Phukan; Prasenjit Manna; Wahengbam Romi; Pankaj Bharali; Dibyajyoti Ozah; Ravi Kumar Sahu; Prachurjya Dutta; Moirangthem Goutam Singh; Gayatri Gogoi; Yasmin Begam Tapadar; Elapavalooru Vssk Babu; Rajeev K Sukumaran; Aishwarya R Nair; Anoop Puthiyamadam; Prajeesh Kooloth Valappil; Adrash Velayudhan Pillai Prasannakumari; Kalpana Chodankar; Samir Damare; Ved Varun Agrawal; Kumardeep Chaudhary; Anurag Agrawal; Shantanu Sengupta; Debasis Dash
Journal:  Comput Biol Med       Date:  2022-04-25       Impact factor: 6.698

Review 10.  SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review.

Authors:  Aliisa Heiskanen; Yannick Galipeau; Marc-André Langlois; Julian Little; Curtis L Cooper
Journal:  Int J Environ Res Public Health       Date:  2022-09-15       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.